Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORAN
1726
DELISTED
Orange
ORAN
| $5.64M | ﹤0.01% |
520,455
-102,201
| -16% | -$1.15M |
|
1727
Alkermes
ALKS
$8.1B
| $5.63M | ﹤0.01% |
182,421
-24,141
| -12% | -$682K |
|
1728
Parsons
PSN
$4.19B
| $5.61M | ﹤0.01% |
166,065
-15,998
| -9% | -$584K |
|
1729
PUT
ARK Genomic Revolution ETF
ARKG
$1.51B
| $5.6M | ﹤0.01% |
74,900
+29,800
| +66% | +$2.5M |
|
1730
Essent Group
ESNT
$6.31B
| $5.59M | ﹤0.01% |
127,133
-107,674
| -46% | -$4.89M |
|
1731
PUT
Bausch Health
BHC
$1.68B
| $5.58M | ﹤0.01% |
+200,000
| New | +$5.67M |
|
1732
CALL
Natera
NTRA
$35.7B
| $5.57M | ﹤0.01% |
50,000
+28,000
| +127% | +$3.21M |
|
1733
CVR Partners
UAN
$1.28B
| $5.57M | ﹤0.01% |
79,839
-66,869
| -46% | -$4.03M |
|
1734
Blackbaud
BLKB
$1.95B
| $5.55M | ﹤0.01% |
78,933
+5,137
| +7% | +$361K |
|
|
FTCH
1735
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $5.53M | ﹤0.01% |
147,633
-42,405
| -22% | -$1.88M |
|
1736
PUT
ARK Innovation ETF
ARKK
$5.61B
| $5.53M | ﹤0.01% |
50,000
-50,000
| -50% | -$6.02M |
|
1737
Fomento Económico Mexicano
FMX
$41.8B
| $5.52M | ﹤0.01% |
63,670
-26,373
| -29% | -$2.27M |
|
1738
Builders FirstSource
BLDR
$7.47B
| $5.52M | ﹤0.01% |
106,668
-13,524
| -11% | -$661K |
|
1739
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11B
| $5.52M | ﹤0.01% |
41,279
-15,559
| -27% | -$2.14M |
|
1740
iShares Russell 1000 ETF
IWB
$47.4B
| $5.5M | ﹤0.01% |
22,769
-120,149
| -84% | -$29.9M |
|
1741
Denali Therapeutics
DNLI
$3.76B
| $5.5M | ﹤0.01% |
109,025
+43,778
| +67% | +$2.47M |
|
1742
iShares MSCI Canada ETF
EWC
$6.11B
| $5.49M | ﹤0.01% |
151,347
+93,494
| +162% | +$3.47M |
|
1743
Asbury Automotive
ABG
$4.67B
| $5.49M | ﹤0.01% |
27,894
-11,683
| -30% | -$2.2M |
|
1744
Regenxbio
RGNX
$611M
| $5.48M | ﹤0.01% |
130,752
-11,765
| -8% | -$423K |
|
|
SRCL
1745
DELISTED
Stericycle Inc
SRCL
| $5.47M | ﹤0.01% |
80,549
-1,457
| -2% | -$101K |
|
|
TELL
1746
DELISTED
Tellurian Inc.
TELL
| $5.47M | ﹤0.01% |
1,400,138
+489,875
| +54% | +$1.67M |
|
1747
ROBO Global Robotics & Automation Index ETF
ROBO
$1.87B
| $5.47M | ﹤0.01% |
84,958
-45,334
| -35% | -$3.01M |
|
|
XONE
1748
DELISTED
The ExOne Company
XONE
| $5.47M | ﹤0.01% |
233,982
+229,938
| +5,686% | +$4.82M |
|
|
CLDL
1749
DELISTED
Direxion Daily Cloud Computing Bull 2X Shares
CLDL
| $5.45M | ﹤0.01% |
200,000
| – | – |
|
|
TWTR
1750
PUT
DELISTED
Twitter, Inc.
TWTR
| $5.44M | ﹤0.01% |
90,000
| – | – |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.